GAM Holding’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,902
Closed -$358K 331
2021
Q4
$358K Hold
3,902
0.02% 258
2021
Q3
$495K Buy
3,902
+1
+0% +$146 0.02% 235
2021
Q2
$649K Sell
3,901
-74
-2% -$12K 0.03% 243
2021
Q1
$722K Buy
+3,975
New +$922K 0.03% 248
2020
Q4
Sell
-21,416
Closed -$4.7M 332
2020
Q3
$4.7M Sell
21,416
-7,830
-27% -$1.66M 0.28% 107
2020
Q2
$5.58M Sell
29,246
-11,100
-28% -$1.95M 0.35% 83
2020
Q1
$6.25M Hold
40,346
0.43% 64
2019
Q4
$3.38M Hold
40,346
0.16% 170
2019
Q3
$2.73M Hold
40,346
0.12% 197
2019
Q2
$2.68M Hold
40,346
0.1% 212
2019
Q1
$2.24M Buy
+40,346
New +$2.46M 0.09% 239

Other funds holding TDOC

GAM Holding's TDOC Position: Q1 2022 in Review

GAM Holding sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 3,902 shares — an estimated $358K sold.

GAM Holding first reported a position in TDOC in Q1 2019 and held it in 11 quarters. The position peaked at $6.25M in Q1 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • GAM Holding reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • GAM Holding sold 3,902 Teladoc Health shares in Q1 2022, an estimated $358K.
  • GAM Holding first reported a position in Teladoc Health in Q1 2019 and held it in 11 quarters.
  • GAM Holding's Teladoc Health position peaked at $6.25M in Q1 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on GAM Holding's 13F filing for Q1 2022, filed 6 May 2022.